1. Home
  2. INAB vs ATER Comparison

INAB vs ATER Comparison

Compare INAB & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • ATER
  • Stock Information
  • Founded
  • INAB 2016
  • ATER 2014
  • Country
  • INAB United States
  • ATER United States
  • Employees
  • INAB N/A
  • ATER N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • INAB Health Care
  • ATER Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • ATER Nasdaq
  • Market Cap
  • INAB 24.0M
  • ATER 22.8M
  • IPO Year
  • INAB 2021
  • ATER N/A
  • Fundamental
  • Price
  • INAB $0.26
  • ATER $2.20
  • Analyst Decision
  • INAB Strong Buy
  • ATER Strong Buy
  • Analyst Count
  • INAB 3
  • ATER 1
  • Target Price
  • INAB $7.75
  • ATER N/A
  • AVG Volume (30 Days)
  • INAB 893.3K
  • ATER 46.4K
  • Earning Date
  • INAB 03-13-2025
  • ATER 03-11-2025
  • Dividend Yield
  • INAB N/A
  • ATER N/A
  • EPS Growth
  • INAB N/A
  • ATER N/A
  • EPS
  • INAB N/A
  • ATER N/A
  • Revenue
  • INAB N/A
  • ATER $107,193,000.00
  • Revenue This Year
  • INAB N/A
  • ATER N/A
  • Revenue Next Year
  • INAB N/A
  • ATER $5.47
  • P/E Ratio
  • INAB N/A
  • ATER N/A
  • Revenue Growth
  • INAB N/A
  • ATER N/A
  • 52 Week Low
  • INAB $0.22
  • ATER $0.23
  • 52 Week High
  • INAB $1.74
  • ATER $3.95
  • Technical
  • Relative Strength Index (RSI)
  • INAB 40.24
  • ATER 39.46
  • Support Level
  • INAB $0.27
  • ATER $2.18
  • Resistance Level
  • INAB $0.33
  • ATER $2.35
  • Average True Range (ATR)
  • INAB 0.04
  • ATER 0.13
  • MACD
  • INAB -0.00
  • ATER -0.01
  • Stochastic Oscillator
  • INAB 5.70
  • ATER 3.85

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: